PP
PBYI icon

Paloma Partners’s Puma Biotechnology PBYI Stock Holding History

Paloma Partners’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-31,024
Closed -$313K – 2090
2020
Q3 		$313K Buy
+31,024
New +$316K 0.01% 1460
2020
Q1 		– Sell
-30,206
Closed -$265K – 1860
2019
Q4 		$265K Buy
+30,206
New +$250K ﹤0.01% 1831
2019
Q2 		– Sell
-11,516
Closed -$447K – 2078
2019
Q1 		$447K Buy
+11,516
New +$352K 0.01% 1125
2015
Q3 		– Sell
-28,453
Closed -$3.32M – 1834
2015
Q2 		$3.32M Buy
+28,453
New +$5.15M 0.06% 281

Other funds holding PBYI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Paloma Partners's PBYI Position: Q4 2020 in Review

Paloma Partners sold out of Puma Biotechnology (PBYI) in Q4 2020, closing a stake of 31,024 shares — an estimated $313K sold.

Paloma Partners first reported a position in PBYI in Q2 2015 and held it in 4 quarters. The position peaked at $3.32M in Q2 2015. 123 funds tracked by Wall St. Rank hold PBYI as of Q4 2020.

  • Paloma Partners reported no remaining Puma Biotechnology position as of Q4 2020 after selling out during the quarter.
  • Paloma Partners sold 31,024 Puma Biotechnology shares in Q4 2020, an estimated $313K.
  • Paloma Partners first reported a position in Puma Biotechnology in Q2 2015 and held it in 4 quarters.
  • Paloma Partners's Puma Biotechnology position peaked at $3.32M in Q2 2015.
  • 123 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.